Screening is not generally recommended for women at average risk due to the potential for false positives and subsequent unnecessary procedures. However, women with a family history of ovarian or breast cancer, or those with known genetic mutations like BRCA1 or BRCA2, are considered high risk and may benefit from more vigilant monitoring.
